IMA (Ikena Oncology, Inc.) Sotuvning yalpi marjinal rentabelligi

ImageneBio Inc (IMA) kompaniyasining rasmiy ramzlari

ImageneBio Inc (IMA) kompaniyasining maqsadli onkologiya va o'simta metabolizmini o'rganishdagi istiqbollari ijobiy fon yaratmoqda, bu esa yalpi foyda marjasi tendentsiyasida aks etgan. 0.00 qiymati ushbu parametrning joriy holatini ifodalaydi. Samaradorlik xarajatlarni kamaytirish uchun klinik sinovlarni autsorsing qilish orqali qo'llab-quvvatlanmoqda, AQSh muhitining barqarorligi va ishlanmalarning gumanitar maqomi esa geosiyosiy risklarni minimallashtiradi.

Yalpi rentabellik: ImageneBio Inc (IMA) 29.07.2025 - 19.11.2026 uchun

ImageneBio (IMA) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Fundamental baholash:IMA - ikenaoncology.com
Ikena Oncology brend mahsuloti

To'g'ridan-to'g'ri xarajatlardan keyingi doimiy yuqori foyda marjasi biznesning uzoq muddatli barqarorligini va qo'shimcha qiymat yaratish qobiliyatini tasdiqlaydi. Val marja farqini tahlil qilish orqali investorlar xarajatlarni qoplash samaradorligini baholaydilar, bu esa ImageneBio Inc (IMA) uchun klinik sinovlarni kengaytirish va maqsadli onkologiya sektorida strategik hamkorlarni qidirishda juda muhimdir.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik enGene Holdings Inc.|RAPT: Yalpi foyda normasi|Yalpi marja JBIO|Yalpi foyda bo'yicha rentabellik aclaristx.com ACRS|Yalpi rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Yalpi foyda marjasi|Cabaletta Bio, Inc - Yalpi marja|Yalpi foyda marjasi Ventyx Biosciences|THTX (theratech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Yalpi marja|Yalpi foyda marjasi Agenus Inc. AGEN|Yalpi foyda bo'yicha rentabellik CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Yalpi foyda normasi|Yalpi rentabellik atyrpharma.com ATYR|Yalpi marja Adagene Corp ADAG|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik